Cargando…

Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review

Metabolic syndrome includes a series of metabolic abnormalities that leads to diabetes mellitus and cardiovascular diseases. Plant extracts, due to their unique advantages like anti-inflammatory, antioxidant, and insulin sensitizing properties, are interesting therapeutic options to manage MetS; how...

Descripción completa

Detalles Bibliográficos
Autores principales: Nouri, Zeinab, Hajialyani, Marziyeh, Izadi, Zhila, Bahramsoltani, Roodabeh, Farzaei, Mohammad Hosein, Abdollahi, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240035/
https://www.ncbi.nlm.nih.gov/pubmed/32478050
http://dx.doi.org/10.3389/fbioe.2020.00425
_version_ 1783536799892635648
author Nouri, Zeinab
Hajialyani, Marziyeh
Izadi, Zhila
Bahramsoltani, Roodabeh
Farzaei, Mohammad Hosein
Abdollahi, Mohammad
author_facet Nouri, Zeinab
Hajialyani, Marziyeh
Izadi, Zhila
Bahramsoltani, Roodabeh
Farzaei, Mohammad Hosein
Abdollahi, Mohammad
author_sort Nouri, Zeinab
collection PubMed
description Metabolic syndrome includes a series of metabolic abnormalities that leads to diabetes mellitus and cardiovascular diseases. Plant extracts, due to their unique advantages like anti-inflammatory, antioxidant, and insulin sensitizing properties, are interesting therapeutic options to manage MetS; however, the poor solubility and low bioavailability of lipophilic bioactive components in the herbal extracts are two critical challenges. Nano-scale delivery systems are suitable to improve delivery of herbal extracts. This review, for the first time, focuses on nanoformulations of herbal extracts in MetS and related complications. Included studies showed that several forms of nano drug delivery systems such as nanoemulsions, solid lipid nanoparticles, nanobiocomposites, and green-synthesized silver, gold, and zinc oxide nanoparticles have been developed using herbal extracts. It was shown that the method of preparation and related parameters such as temperature and type of polymer are important factors affecting physicochemical stability and therapeutic activity of the final product. Many of these formulations could successfully decrease the lipid profile, inflammation, oxidative damage, and insulin resistance in in vitro and in vivo models of MetS-related complications. Further studies are still needed to confirm the safety and efficacy of these novel herbal formulations for clinical application.
format Online
Article
Text
id pubmed-7240035
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72400352020-05-29 Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review Nouri, Zeinab Hajialyani, Marziyeh Izadi, Zhila Bahramsoltani, Roodabeh Farzaei, Mohammad Hosein Abdollahi, Mohammad Front Bioeng Biotechnol Bioengineering and Biotechnology Metabolic syndrome includes a series of metabolic abnormalities that leads to diabetes mellitus and cardiovascular diseases. Plant extracts, due to their unique advantages like anti-inflammatory, antioxidant, and insulin sensitizing properties, are interesting therapeutic options to manage MetS; however, the poor solubility and low bioavailability of lipophilic bioactive components in the herbal extracts are two critical challenges. Nano-scale delivery systems are suitable to improve delivery of herbal extracts. This review, for the first time, focuses on nanoformulations of herbal extracts in MetS and related complications. Included studies showed that several forms of nano drug delivery systems such as nanoemulsions, solid lipid nanoparticles, nanobiocomposites, and green-synthesized silver, gold, and zinc oxide nanoparticles have been developed using herbal extracts. It was shown that the method of preparation and related parameters such as temperature and type of polymer are important factors affecting physicochemical stability and therapeutic activity of the final product. Many of these formulations could successfully decrease the lipid profile, inflammation, oxidative damage, and insulin resistance in in vitro and in vivo models of MetS-related complications. Further studies are still needed to confirm the safety and efficacy of these novel herbal formulations for clinical application. Frontiers Media S.A. 2020-05-14 /pmc/articles/PMC7240035/ /pubmed/32478050 http://dx.doi.org/10.3389/fbioe.2020.00425 Text en Copyright © 2020 Nouri, Hajialyani, Izadi, Bahramsoltani, Farzaei and Abdollahi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Nouri, Zeinab
Hajialyani, Marziyeh
Izadi, Zhila
Bahramsoltani, Roodabeh
Farzaei, Mohammad Hosein
Abdollahi, Mohammad
Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
title Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
title_full Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
title_fullStr Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
title_full_unstemmed Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
title_short Nanophytomedicines for the Prevention of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review
title_sort nanophytomedicines for the prevention of metabolic syndrome: a pharmacological and biopharmaceutical review
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240035/
https://www.ncbi.nlm.nih.gov/pubmed/32478050
http://dx.doi.org/10.3389/fbioe.2020.00425
work_keys_str_mv AT nourizeinab nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview
AT hajialyanimarziyeh nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview
AT izadizhila nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview
AT bahramsoltaniroodabeh nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview
AT farzaeimohammadhosein nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview
AT abdollahimohammad nanophytomedicinesforthepreventionofmetabolicsyndromeapharmacologicalandbiopharmaceuticalreview